The evaluation of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005
Challenges in the management of SCLC Part 2: Extensive disease, prophylaxis/treatment of brain metastases Source: ERS webinar 2021: Challenges in the management of SCLC Part 2: Extensive disease, prophylaxis/treatment of brain metastases Year: 2021
Modern profiling of advanced lung cancer at the primary diagnosis and during therapy Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer Year: 2018
A preliminary study on targeted therapies in advanced lung cancer patients Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009
Coexistence of chronic obstructive pulmonary disease in patients with advanced non-small cell lung cancer and impact on survival Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
Do cavitating non-small cell lung cancer patients have a more aggressive disease? Source: Eur Respir J 2006; 28: Suppl. 50, 84s Year: 2006
Accompanying diseases in lung cancer patients Source: Eur Respir J 2006; 28: Suppl. 50, 127s Year: 2006
Current neoadjuvant/adjuvant treatment for advanced stage lung cancer Source: International Congress 2014 – PG19 Surgery for advanced stage lung cancer Year: 2014
Prevalence and characterization of interstitial lung disease in a lung cancer screening program Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019
Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy Source: Eur Respir J 2012; 39: 1437-1442 Year: 2012
Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK -rearranged non-small cell lung cancer Source: Eur Respir J, 51 (5) 1702431; 10.1183/13993003.02431-2017 Year: 2018
Characteristics of lung cancer patients in Serbia and subsequent treatment in advanced NSCLC over time – epidemiology study Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
Clinicopathologic features of patients with non-small cell lung cancer and chronic obstructive pulmonary disease undergoing lung cancer surgery Source: Virtual Congress 2020 – Localised non-small cell lung cancer Year: 2020
Locally advanced and metastatic lung cancer management delay: Tunisian department experience Source: International Congress 2016 – Quality management and quality of life in lung cancer Year: 2016
Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018
Coexistence of COPD in lung cancer patients Source: Eur Respir J 2001; 18: Suppl. 33, 66s Year: 2001
Pancreatic polypeptide is increased in patients with advanced malignant disease including lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 232s Year: 2002
Features affecting stages of patients with lung cancer at diagnosis Source: Eur Respir J 2005; 26: Suppl. 49, 536s Year: 2005
Management of patients with non-small-cell lung cancer Source: ERS Live 2007 Year: 2007